Clinical trial
A Randomized, Double-blind, Multicenter, Parallel Controlled Clinical Trial of Danhong Injection in the Treatment of Unstable Angina Pectoris
NCT02007187 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Multicenter, Parallel Controlled Clinical Trial of Danhong Injection in the Treatment of Unstable Angina Pectoris
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- November 30, 2017
- Enrollment
- 160 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
unstable angina pectoris